Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Christopher Gibson. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Christopher Gibson har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:RXRX / Recursion Pharmaceuticals, Inc. | Chief Executive Officer, Director | 954 229 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Christopher Gibson. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp RXRX / Recursion Pharmaceuticals, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i RXRX / Recursion Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i RXRX / Recursion Pharmaceuticals, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Christopher Gibson som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −20 000 | 954 229 | −2,05 | |||
2025-09-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −100 000 | 974 229 | −9,31 | 4,71 | −471 000 | 4 588 619 |
2025-09-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 120 000 | 1 074 229 | 12,58 | |||
2025-08-28 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −100 000 | 954 229 | −9,49 | 4,84 | −484 000 | 4 618 468 |
2025-08-28 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 100 000 | 1 054 229 | 10,48 | |||
2025-08-19 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
F - Taxes | −40 390 | 954 229 | −4,06 | 5,64 | −227 800 | 5 381 852 | |
2025-08-13 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −17 875 | 0 | −100,00 | 5,28 | −94 380 | |
2025-08-13 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 17 875 | 17 875 | ||||
2025-08-13 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −100 000 | 0 | −100,00 | 5,28 | −528 000 | |
2025-08-13 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 100 000 | 100 000 | ||||
2025-08-13 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −10 000 | 994 619 | −1,00 | |||
2025-08-13 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 300 | 1 004 619 | −33,24 | 5,28 | −2 641 584 | 5 304 388 |
2025-08-13 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 423 666 | 1 504 919 | 39,18 | |||
2025-05-19 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
F - Taxes | −36 197 | 1 081 253 | −3,24 | 4,25 | −153 837 | 4 595 325 | |
2025-03-28 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −138 574 | 1 117 450 | −11,03 | 6,04 | −836 987 | 6 749 398 |
2025-03-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 1 256 024 | −1,57 | 6,37 | −127 400 | 8 000 873 |
2025-03-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 1 276 024 | 1,59 | |||
2025-03-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 1 256 024 | −1,57 | 6,58 | −131 600 | 8 264 638 |
2025-03-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 1 276 024 | 1,59 | |||
2025-02-20 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
F - Taxes | −17 132 | 1 256 024 | −1,35 | 10,64 | −182 284 | 13 364 095 | |
2025-02-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 1 273 156 | −1,55 | 8,12 | −162 400 | 10 338 027 |
2025-02-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 1 293 156 | 1,57 | |||
2025-02-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 1 273 156 | −1,55 | 7,68 | −153 600 | 9 777 838 |
2025-02-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 1 293 156 | 1,57 | |||
2025-02-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
F - Taxes | −5 569 | 1 273 156 | −0,44 | 7,25 | −40 375 | 9 230 381 | |
2025-02-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
A - Award | 16 809 | 1 278 725 | 1,33 | ||||
2025-02-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
A - Award | 525 283 | 1 261 916 | 71,31 | ||||
2025-01-13 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 736 633 | −2,64 | 7,05 | −141 000 | 5 193 263 |
2025-01-13 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 756 633 | 2,72 | |||
2025-01-13 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 736 633 | −2,64 | 7,31 | −146 200 | 5 384 787 |
2025-01-13 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 756 633 | 2,72 | |||
2024-12-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 736 633 | −2,64 | 7,12 | −142 400 | 5 244 827 |
2024-12-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 756 633 | 2,72 | |||
2024-12-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 736 633 | −2,64 | 7,16 | −143 200 | 5 274 292 |
2024-12-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 756 633 | 2,72 | |||
2024-11-19 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
F - Taxes | −26 023 | 736 633 | −3,41 | 6,18 | −160 692 | 4 548 709 | |
2024-11-15 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 762 656 | −2,56 | 7,35 | −147 000 | 5 605 522 |
2024-11-15 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 782 656 | 2,62 | |||
2024-11-15 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 762 656 | −2,56 | 7,74 | −154 800 | 5 902 957 |
2024-11-15 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 782 656 | 2,62 | |||
2024-10-04 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 762 656 | −2,56 | 6,08 | −121 600 | 4 636 948 |
2024-10-04 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 782 656 | 2,62 | |||
2024-10-04 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 762 656 | −2,56 | 6,16 | −123 200 | 4 697 961 |
2024-10-04 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 782 656 | 2,62 | |||
2024-09-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 762 656 | −2,56 | 6,14 | −122 800 | 4 682 708 |
2024-09-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 782 656 | 2,62 | |||
2024-09-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 762 656 | −2,56 | 6,04 | −120 800 | 4 606 442 |
2024-09-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 782 656 | 2,62 | |||
2024-08-30 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | 5 000 | 762 656 | 0,66 | 2,48 | 12 400 | 1 891 387 | |
2024-08-29 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | 5 000 | 757 656 | 0,66 | 2,48 | 12 400 | 1 878 987 | |
2024-08-28 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | 5 000 | 752 656 | 0,67 | 2,48 | 12 400 | 1 866 587 | |
2024-08-27 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | 5 000 | 747 656 | 0,67 | 2,48 | 12 400 | 1 854 187 | |
2024-08-26 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | 5 000 | 742 656 | 0,68 | 2,48 | 12 400 | 1 841 787 | |
2024-08-23 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | 5 000 | 737 656 | 0,68 | 2,48 | 12 400 | 1 829 387 | |
2024-08-19 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
F - Taxes | −26 082 | 732 656 | −3,44 | 6,69 | −174 489 | 4 901 469 | |
2024-08-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 758 738 | −2,57 | 6,50 | −130 000 | 4 931 797 |
2024-08-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 778 738 | 2,64 | |||
2024-08-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −30 000 | 758 738 | −3,80 | 7,10 | −213 000 | 5 387 040 |
2024-08-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 30 000 | 788 738 | 3,95 | |||
2024-07-12 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 100 000 | 908 738 | 12,36 | |||
2024-07-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −50 000 | 758 738 | −6,18 | 7,47 | −373 500 | 5 667 773 |
2024-07-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 50 000 | 808 738 | 6,59 | |||
2024-07-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −50 000 | 758 738 | −6,18 | 7,48 | −374 000 | 5 675 360 |
2024-07-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 50 000 | 808 738 | 6,59 | |||
2024-07-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −25 000 | 758 738 | −3,19 | |||
2024-06-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −50 000 | 708 738 | −6,59 | 9,00 | −450 000 | 6 378 642 |
2024-06-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −50 000 | 758 738 | −6,18 | 8,42 | −421 000 | 6 388 574 |
2024-06-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −25 000 | 808 738 | −3,00 | |||
2024-06-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 25 000 | 833 738 | 3,09 | |||
2024-05-17 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
F - Taxes | −26 082 | 808 738 | −3,12 | 10,01 | −261 081 | 8 095 467 | |
2024-05-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −21 296 | 834 820 | −2,49 | 8,47 | −180 377 | 7 070 925 |
2024-05-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 21 296 | 856 116 | 2,55 | |||
2024-05-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −28 704 | 834 820 | −3,32 | 8,47 | −243 123 | 7 070 925 |
2024-05-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −50 000 | 863 524 | −5,47 | 7,73 | −386 500 | 6 675 041 |
2024-05-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −25 000 | 913 524 | −2,66 | |||
2024-04-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −25 000 | 0 | −100,00 | 9,02 | −225 500 | |
2024-04-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 25 000 | 25 000 | ||||
2024-04-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −40 000 | 938 524 | −4,09 | 9,02 | −360 800 | 8 465 486 |
2024-04-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −25 000 | 0 | −100,00 | 8,84 | −221 000 | |
2024-04-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 25 000 | 25 000 | ||||
2024-04-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −40 000 | 978 524 | −3,93 | 8,84 | −353 600 | 8 650 152 |
2024-04-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −25 000 | 1 018 524 | −2,40 | |||
2024-04-01 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −25 000 | 0 | −100,00 | 10,10 | −252 500 | |
2024-04-01 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 25 000 | 25 000 | ||||
2024-04-01 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −40 000 | 1 043 524 | −3,69 | 10,10 | −404 000 | 10 539 592 |
2024-04-01 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −25 000 | 1 083 524 | −2,26 | |||
2024-03-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 11,56 | −11 562 | |
2024-03-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2024-03-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 0 | −100,00 | 11,55 | −231 002 | |
2024-03-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 20 000 | ||||
2024-03-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −4 000 | 0 | −100,00 | 11,56 | −46 259 | |
2024-03-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 4 000 | 4 000 | ||||
2024-03-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −36 319 | 1 108 524 | −3,17 | 11,86 | −430 682 | 13 145 210 |
2024-03-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 8 674 | 1 144 843 | 0,76 | 11,40 | 98 884 | 13 051 210 |
2024-03-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 1 136 169 | 2,83 | 2,48 | 77 500 | 2 817 699 |
2024-03-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −10 000 | 1 104 919 | −0,90 | |||
2024-03-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 10 000 | 1 114 919 | 0,91 | |||
2024-02-16 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
F - Taxes | −11 148 | 1 104 919 | −1,00 | 12,43 | −138 570 | 13 734 143 | |
2024-02-13 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
F - Taxes | −3 233 | 1 116 067 | −0,29 | 10,09 | −32 621 | 11 261 116 | |
2024-02-13 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
A - Award | 333 449 | 1 119 300 | 42,43 | ||||
2024-02-13 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
A - Award | 11 148 | 785 851 | 1,44 | ||||
2024-02-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −48 272 | 774 703 | −5,87 | 9,22 | −444 981 | 7 141 367 |
2024-02-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 822 975 | 3,95 | 2,48 | 77 500 | 2 040 978 |
2024-02-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −10 000 | 791 725 | −1,25 | |||
2024-02-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 10 000 | 801 725 | 1,26 | |||
2024-01-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 9,49 | −9 494 | |
2024-01-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2024-01-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 0 | −100,00 | 9,51 | −190 240 | |
2024-01-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 20 000 | ||||
2024-01-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −4 000 | 0 | −100,00 | 9,51 | −38 029 | |
2024-01-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 4 000 | 4 000 | ||||
2024-01-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −30 853 | 791 725 | −3,75 | 9,49 | −292 804 | 7 513 708 |
2024-01-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 822 578 | 3,95 | 2,48 | 77 500 | 2 039 993 |
2024-01-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −10 000 | 791 328 | −1,25 | |||
2024-01-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 10 000 | 801 328 | 1,26 | |||
2023-12-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −59 829 | 791 328 | −7,03 | 7,49 | −448 394 | 5 930 687 |
2023-12-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 851 157 | 3,81 | 2,48 | 77 500 | 2 110 869 |
2023-12-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −10 000 | 819 907 | −1,20 | |||
2023-12-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 10 000 | 829 907 | 1,22 | |||
2023-11-17 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
F - Taxes | −16 913 | 819 907 | −2,02 | 7,18 | −121 435 | 5 886 932 | |
2023-11-17 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −10 000 | 836 820 | −1,18 | |||
2023-11-17 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 10 000 | 846 820 | 1,20 | |||
2023-11-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 5,14 | −5 137 | |
2023-11-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2023-11-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 0 | −100,00 | 5,11 | −102 294 | |
2023-11-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 20 000 | ||||
2023-11-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −4 000 | 0 | −100,00 | 5,14 | −20 564 | |
2023-11-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 4 000 | 4 000 | ||||
2023-11-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −37 177 | 836 820 | −4,25 | 5,20 | −193 306 | 4 351 129 |
2023-11-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 873 997 | 3,71 | 2,48 | 77 500 | 2 167 513 |
2023-10-18 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −10 000 | 842 747 | −1,17 | |||
2023-10-18 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 10 000 | 852 747 | 1,19 | |||
2023-10-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −59 794 | 842 747 | −6,63 | 7,21 | −431 025 | 6 074 942 |
2023-10-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 902 541 | 3,59 | 2,48 | 77 500 | 2 238 302 |
2023-09-19 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −10 000 | 871 291 | −1,13 | |||
2023-09-19 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 10 000 | 881 291 | 1,15 | |||
2023-09-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 8,84 | −8 836 | |
2023-09-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2023-09-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 0 | −100,00 | 8,83 | −176 696 | |
2023-09-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 20 000 | ||||
2023-09-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −4 000 | 0 | −100,00 | 8,83 | −35 335 | |
2023-09-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 4 000 | 4 000 | ||||
2023-09-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −33 765 | 871 291 | −3,73 | 8,78 | −296 575 | 7 652 984 |
2023-09-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 905 056 | 3,58 | 2,48 | 77 500 | 2 244 539 |
2023-08-17 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
F - Taxes | −16 913 | 873 806 | −1,90 | 9,19 | −155 430 | 8 030 277 | |
2023-08-11 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −10 000 | 890 719 | −1,11 | |||
2023-08-11 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 10 000 | 900 719 | 1,12 | |||
2023-08-04 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −4 060 | 890 719 | −0,45 | 13,36 | −54 254 | 11 902 767 |
2023-08-04 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −60 955 | 894 779 | −6,38 | 13,02 | −793 457 | 11 647 428 |
2023-08-04 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 955 734 | 3,38 | 2,48 | 77 500 | 2 370 220 |
2023-08-04 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 8 674 | 924 484 | 0,95 | 11,40 | 98 884 | 10 539 118 |
2023-07-21 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −10 000 | 915 810 | −1,08 | |||
2023-07-21 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 10 000 | 925 810 | 1,09 | |||
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −13 | 0 | −100,00 | 14,85 | −193 | |
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −63 | 13 | −82,89 | 13,75 | −867 | 179 |
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −127 | 76 | −62,56 | 12,36 | −1 569 | 939 |
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −561 | 203 | −73,43 | 11,82 | −6 634 | 2 400 |
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −236 | 764 | −23,60 | 10,87 | −2 565 | 8 305 |
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −550 | 0 | −100,00 | 14,03 | −7 716 | |
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −4 693 | 550 | −89,51 | 12,41 | −58 255 | 6 827 |
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −10 327 | 5 243 | −66,33 | 11,74 | −121 282 | 61 575 |
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −4 430 | 15 570 | −22,15 | 10,84 | −48 013 | 168 751 |
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 20 000 | ||||
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −127 | 0 | −100,00 | 14,06 | −1 786 | |
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −850 | 127 | −87,00 | 12,41 | −10 546 | 1 576 |
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −2 173 | 977 | −68,98 | 11,80 | −25 642 | 11 529 |
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −850 | 3 150 | −21,25 | 10,82 | −9 198 | 34 085 |
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 4 000 | 4 000 | ||||
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −17 227 | 915 810 | −1,85 | 14,34 | −247 104 | 13 136 379 |
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −3 270 | 933 037 | −0,35 | 12,39 | −40 506 | 11 557 809 |
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −7 898 | 936 307 | −0,84 | 11,80 | −93 172 | 11 045 520 |
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −3 423 | 944 205 | −0,36 | 10,87 | −37 194 | 10 259 543 |
2023-07-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 947 628 | 3,41 | 2,48 | 77 500 | 2 350 117 |
2023-06-16 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −10 000 | 916 378 | −1,08 | |||
2023-06-16 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 10 000 | 926 378 | 1,09 | |||
2023-06-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −56 436 | 916 378 | −5,80 | 9,05 | −510 808 | 8 294 229 |
2023-06-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 972 814 | 3,32 | 2,48 | 77 500 | 2 412 579 |
2023-05-17 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
F - Taxes | −11 661 | 941 564 | −1,22 | 5,60 | −65 302 | 5 272 758 | |
2023-05-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 4,92 | −4 915 | |
2023-05-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2023-05-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 0 | −100,00 | 4,90 | −98 036 | |
2023-05-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 20 000 | ||||
2023-05-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −4 000 | 0 | −100,00 | 4,91 | −19 623 | |
2023-05-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 4 000 | 4 000 | ||||
2023-05-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −33 073 | 953 225 | −3,35 | 4,71 | −155 761 | 4 489 308 |
2023-05-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 986 298 | 3,27 | 2,48 | 77 500 | 2 446 019 |
2023-05-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −1 338 | 955 048 | −0,14 | |||
2023-05-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 338 | 956 386 | 0,14 | |||
2023-05-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −8 662 | 955 048 | −0,90 | |||
2023-05-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −3 000 | 963 710 | −0,31 | |||
2023-05-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 3 000 | 966 710 | 0,31 | |||
2023-05-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −3 000 | 963 710 | −0,31 | |||
2023-05-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 3 000 | 966 710 | 0,31 | |||
2023-05-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −3 000 | 963 710 | −0,31 | |||
2023-05-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 3 000 | 966 710 | 0,31 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −3 000 | 582 805 | −0,51 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 3 000 | 585 805 | 0,51 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −3 000 | 582 805 | −0,51 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 3 000 | 585 805 | 0,51 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −3 000 | 582 805 | −0,51 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 3 000 | 585 805 | 0,51 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −3 000 | 582 805 | −0,51 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 3 000 | 585 805 | 0,51 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −3 000 | 582 805 | −0,51 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 3 000 | 585 805 | 0,51 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −3 000 | 582 805 | −0,51 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 3 000 | 585 805 | 0,51 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −3 000 | 582 805 | −0,51 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 3 000 | 585 805 | 0,51 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −12 000 | 582 805 | −2,02 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 12 000 | 594 805 | 2,06 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −12 000 | 582 805 | −2,02 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 12 000 | 594 805 | 2,06 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −12 000 | 582 805 | −2,02 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 12 000 | 594 805 | 2,06 | |||
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 582 805 | −3,08 | 7,39 | −136 669 | 4 305 472 |
2023-04-28 |
|
4/A | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 601 305 | 3,17 | |||
2023-04-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −40 000 | 906 710 | −4,23 | 6,64 | −265 672 | 6 022 186 |
2023-04-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −13 327 | 946 710 | −1,39 | 6,46 | −86 038 | 6 111 865 |
2023-04-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 960 037 | 3,36 | 2,48 | 77 500 | 2 380 892 |
2023-04-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −10 000 | 928 787 | −1,07 | |||
2023-03-15 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −3 000 | 938 787 | −0,32 | |||
2023-03-15 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 3 000 | 941 787 | 0,32 | |||
2023-03-10 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −15 000 | 938 787 | −1,57 | 7,77 | −116 620 | 7 298 787 |
2023-03-10 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 8,09 | −8 087 | |
2023-03-10 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2023-03-10 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −20 000 | 0 | −100,00 | 8,10 | −161 900 | |
2023-03-10 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 20 000 | 20 000 | ||||
2023-03-10 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −4 000 | 0 | −100,00 | 8,09 | −32 362 | |
2023-03-10 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 4 000 | 4 000 | ||||
2023-03-10 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −10 000 | 953 787 | −1,04 | |||
2023-03-10 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −70 890 | 963 787 | −6,85 | 8,10 | −573 925 | 7 802 820 |
2023-03-10 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 93 750 | 1 034 677 | 9,96 | 2,48 | 232 500 | 2 565 999 |
2023-03-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 7,91 | −7 909 | |
2023-03-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2023-03-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2023-03-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 7,91 | −7 906 | |
2023-03-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 7,90 | −3 952 | |
2023-03-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2023-03-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 940 927 | −1,93 | 7,92 | −146 502 | 7 451 201 |
2023-03-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 956 427 | 1,97 | |||
2023-02-17 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
F - Taxes | −1 346 | 940 927 | −0,14 | 8,44 | −11 360 | 7 941 424 | |
2023-02-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 9,20 | −9 202 | |
2023-02-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2023-02-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2023-02-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 9,21 | −9 208 | |
2023-02-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 9,21 | −4 604 | |
2023-02-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2023-02-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 942 273 | −1,93 | 9,22 | −170 548 | 8 686 626 |
2023-02-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 960 773 | 1,96 | |||
2023-02-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
F - Taxes | −1 382 | 942 273 | −0,15 | 8,55 | −11 816 | 8 056 434 | |
2023-02-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
A - Award | 11 050 | 943 655 | 1,18 | ||||
2023-02-03 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
A - Award | 406 800 | 932 605 | 77,37 | ||||
2023-01-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 7,38 | −7 382 | |
2023-01-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2023-01-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2023-01-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 7,39 | −7 391 | |
2023-01-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 7,38 | −3 689 | |
2023-01-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2023-01-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 525 805 | −3,40 | 7,39 | −136 669 | 3 884 384 |
2023-01-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 544 305 | 3,52 | |||
2023-01-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −3 000 | 525 805 | −0,57 | |||
2023-01-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −3 000 | 528 805 | −0,56 | |||
2023-01-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −3 000 | 531 805 | −0,56 | |||
2023-01-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −3 000 | 534 805 | −0,56 | |||
2023-01-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −3 000 | 537 805 | −0,55 | |||
2023-01-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −3 000 | 540 805 | −0,55 | |||
2023-01-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −3 000 | 543 805 | −0,55 | |||
2023-01-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −12 000 | 546 805 | −2,15 | |||
2023-01-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −12 000 | 558 805 | −2,10 | |||
2023-01-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −12 000 | 570 805 | −2,06 | |||
2022-12-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 9,28 | −9 277 | |
2022-12-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 9,28 | −9 277 | |
2022-12-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-12-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-12-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 9,26 | −4 632 | |
2022-12-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2022-12-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 582 805 | −3,08 | 9,28 | −171 615 | 5 406 391 |
2022-12-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 601 305 | 3,17 | |||
2022-12-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 710 | 582 805 | −3,11 | 8,77 | −164 145 | 5 113 007 |
2022-12-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 601 515 | 5,48 | 2,48 | 77 500 | 1 491 757 |
2022-11-17 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
F - Taxes | −5 751 | 570 265 | −1,00 | 11,86 | −68 207 | 6 763 343 | |
2022-11-04 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 10,10 | −10 099 | |
2022-11-04 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-11-04 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-11-04 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 10,10 | −10 098 | |
2022-11-04 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 10,11 | −5 055 | |
2022-11-04 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2022-11-04 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 576 016 | −3,11 | 10,11 | −187 037 | 5 823 579 |
2022-11-04 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 594 516 | 3,21 | |||
2022-11-04 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 193 | 576 016 | −3,06 | 9,89 | −179 911 | 5 696 222 |
2022-11-04 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 594 209 | 5,55 | 2,48 | 77 500 | 1 473 638 |
2022-10-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 11,64 | −11 641 | |
2022-10-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-10-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-10-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 11,64 | −11 643 | |
2022-10-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 11,64 | −5 821 | |
2022-10-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2022-10-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 562 959 | −3,18 | 11,65 | −215 551 | 6 559 260 |
2022-10-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 581 459 | 3,29 | |||
2022-10-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −17 553 | 562 959 | −3,02 | 11,50 | −201 917 | 6 475 886 |
2022-10-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 580 512 | 5,69 | 2,48 | 77 500 | 1 439 670 |
2022-09-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 10,50 | −10 504 | |
2022-09-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-09-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-09-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 10,50 | −10 502 | |
2022-09-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 10,50 | −5 249 | |
2022-09-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2022-09-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 549 262 | −3,26 | 10,49 | −194 041 | 5 761 044 |
2022-09-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 567 762 | 3,37 | |||
2022-09-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 066 | 549 262 | −3,18 | 10,18 | −183 903 | 5 591 213 |
2022-09-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 567 328 | 5,83 | 2,48 | 77 500 | 1 406 973 |
2022-08-17 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
F - Taxes | −5 751 | 536 078 | −1,06 | 12,96 | −74 533 | 6 947 571 | |
2022-08-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 9,45 | −9 447 | |
2022-08-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-08-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-08-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 9,45 | −9 448 | |
2022-08-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 9,44 | −4 722 | |
2022-08-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2022-08-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 541 829 | −3,30 | 9,45 | −174 879 | 5 121 855 |
2022-08-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 560 329 | 3,41 | |||
2022-08-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 325 | 541 829 | −3,27 | 9,53 | −174 562 | 5 161 409 |
2022-08-05 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 560 154 | 5,91 | 2,48 | 77 500 | 1 389 182 |
2022-07-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 9,07 | −9 068 | |
2022-07-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-07-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-07-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 9,07 | −9 070 | |
2022-07-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 9,06 | −4 531 | |
2022-07-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2022-07-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 528 904 | −3,38 | 9,07 | −167 745 | 4 795 731 |
2022-07-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 547 404 | 3,50 | |||
2022-07-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 614 | 528 904 | −3,40 | 9,04 | −168 233 | 4 780 234 |
2022-07-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 547 518 | 6,05 | 2,48 | 77 500 | 1 357 845 |
2022-06-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,34 | −6 341 | |
2022-06-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-06-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-06-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,35 | −6 346 | |
2022-06-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 6,34 | −3 172 | |
2022-06-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2022-06-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 516 268 | −3,46 | 6,34 | −117 381 | 3 275 669 |
2022-06-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 534 768 | 3,58 | |||
2022-06-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −21 190 | 516 268 | −3,94 | 5,87 | −124 385 | 3 030 493 |
2022-06-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 537 458 | 6,17 | 2,48 | 77 500 | 1 332 896 |
2022-05-18 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
F - Taxes | X | −5 764 | 506 208 | −1,13 | 5,67 | −32 682 | 2 870 199 |
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 134 875 | −0,74 | |||
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 134 875 | −0,74 | |||
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −500 | 544 000 | −0,09 | |||
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −18 500 | 6 806 834 | −0,27 | |||
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,44 | −6 439 | |
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,43 | −6 435 | |
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 6,44 | −3 221 | |
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 511 972 | −3,49 | 6,44 | −119 118 | 3 296 485 |
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 530 472 | 3,61 | |||
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 135 875 | −0,73 | |||
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 135 875 | −0,73 | |||
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −500 | 544 500 | −0,09 | |||
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −31 250 | 1 000 000 | −3,03 | |||
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −18 500 | 6 825 334 | −0,27 | |||
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,47 | −6 474 | |
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,48 | −6 481 | |
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 6,47 | −3 235 | |
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 511 972 | −3,49 | 6,48 | −119 852 | 3 316 811 |
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 530 472 | 3,61 | |||
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −13 330 | 511 972 | −2,54 | 6,50 | −86 645 | 3 327 818 |
2022-05-06 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 31 250 | 525 302 | 6,33 | 2,48 | 77 500 | 1 302 749 |
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 136 875 | −0,73 | |||
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 136 875 | −0,73 | |||
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −500 | 545 000 | −0,09 | |||
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −44 010 | 1 031 250 | −4,09 | |||
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −18 500 | 6 843 834 | −0,27 | |||
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,31 | −6 308 | |
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,30 | −6 304 | |
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 6,31 | −3 156 | |
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 494 052 | −3,61 | 6,30 | −116 576 | 3 113 219 |
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 512 552 | 3,74 | |||
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −19 570 | 494 052 | −3,81 | 6,07 | −118 757 | 2 998 056 |
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 44 014 | 513 622 | 9,37 | 2,48 | 109 155 | 1 273 783 |
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 137 875 | −0,72 | |||
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 137 875 | −0,72 | |||
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −500 | 545 500 | −0,09 | |||
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −44 010 | 1 075 264 | −3,93 | |||
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −18 500 | 6 862 334 | −0,27 | |||
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,07 | −6 070 | |
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,07 | −6 069 | |
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 6,05 | −3 026 | |
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 469 608 | −3,79 | 6,08 | −112 545 | 2 856 860 |
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 488 108 | 3,94 | |||
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −19 105 | 469 608 | −3,91 | 6,10 | −116 571 | 2 865 360 |
2022-05-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 44 010 | 488 713 | 9,90 | 2,48 | 109 145 | 1 212 008 |
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Commo Stock |
C - Conversion | X | −12 000 | 6 880 834 | −0,17 | |||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
G - Gift | X | −12 000 | 444 703 | −2,63 | |||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 12 000 | 456 703 | 2,70 | |||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 138 875 | −0,71 | |||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 138 875 | −0,71 | |||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −500 | 546 000 | −0,09 | |||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −44 010 | 1 119 274 | −3,78 | |||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −18 500 | 6 892 834 | −0,27 | |||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,00 | −6 005 | |
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,01 | −6 006 | |
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 5,99 | −2 995 | |
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 444 703 | −3,99 | 6,00 | −111 080 | 2 670 130 |
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 463 203 | 4,16 | |||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −19 453 | 444 703 | −4,19 | 6,07 | −118 095 | 2 699 703 |
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 44 010 | 464 156 | 10,47 | 2,48 | 109 145 | 1 151 107 |
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 139 875 | −0,71 | |||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 139 875 | −0,71 | |||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −500 | 546 500 | −0,09 | |||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −44 010 | 1 163 284 | −3,65 | |||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −18 500 | 6 911 334 | −0,27 | |||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,18 | −6 185 | |
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,18 | −6 184 | |
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 6,19 | −3 097 | |
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 420 146 | −4,22 | 6,19 | −114 461 | 2 599 485 |
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 438 646 | 4,40 | |||
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 655 | 420 146 | −4,25 | 6,44 | −120 168 | 2 706 412 |
2022-04-25 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 44 010 | 438 801 | 11,15 | 2,48 | 109 145 | 1 088 226 |
2022-04-20 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 140 875 | −0,70 | |||
2022-04-20 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 140 875 | −0,70 | |||
2022-04-20 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −500 | 547 000 | −0,09 | |||
2022-04-20 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −44 010 | 1 207 294 | −3,52 | |||
2022-04-20 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −18 500 | 6 929 834 | −0,27 | |||
2022-04-20 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,71 | −6 706 | |
2022-04-20 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-04-20 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-04-20 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,71 | −6 706 | |
2022-04-20 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 6,72 | −3 358 | |
2022-04-20 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2022-04-20 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 394 791 | −4,48 | 6,70 | −123 896 | 2 643 955 |
2022-04-20 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 413 291 | 4,69 | |||
2022-04-20 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −17 336 | 394 791 | −4,21 | 6,99 | −121 175 | 2 759 510 |
2022-04-20 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 44 010 | 412 127 | 11,96 | 2,48 | 109 145 | 1 022 075 |
2022-04-18 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 141 875 | −0,70 | |||
2022-04-18 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 141 875 | −0,70 | |||
2022-04-18 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −500 | 547 500 | −0,09 | |||
2022-04-18 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −44 010 | 1 251 304 | −3,40 | |||
2022-04-18 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −18 500 | 6 948 334 | −0,27 | |||
2022-04-18 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 7,51 | −7 512 | |
2022-04-18 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-04-18 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-04-18 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 7,51 | −7 505 | |
2022-04-18 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 7,50 | −3 750 | |
2022-04-18 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2022-04-18 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 368 117 | −4,79 | 7,51 | −138 874 | 2 763 344 |
2022-04-18 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 386 617 | 5,03 | |||
2022-04-18 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −16 017 | 368 117 | −4,17 | 7,62 | −121 989 | 2 803 653 |
2022-04-18 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 44 010 | 384 134 | 12,94 | 2,48 | 109 145 | 952 652 |
2022-04-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 142 875 | −0,70 | |||
2022-04-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 142 875 | −0,70 | |||
2022-04-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −500 | 548 000 | −0,09 | |||
2022-04-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −44 010 | 1 295 314 | −3,29 | |||
2022-04-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −18 500 | 6 966 834 | −0,26 | |||
2022-04-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,71 | −6 712 | |
2022-04-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-04-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-04-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,71 | −6 712 | |
2022-04-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 6,69 | −3 347 | |
2022-04-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2022-04-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 340 124 | −5,16 | 6,72 | −124 355 | 2 286 280 |
2022-04-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 358 544 | 5,44 | |||
2022-04-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 420 | 340 124 | −5,14 | 6,45 | −118 864 | 2 194 820 |
2022-04-12 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 44 010 | 358 544 | 13,99 | 2,48 | 109 145 | 889 189 |
2022-04-11 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 143 875 | −0,69 | |||
2022-04-11 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 143 875 | −0,69 | |||
2022-04-11 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −500 | 548 500 | −0,09 | |||
2022-04-11 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −44 010 | 1 339 324 | −3,18 | |||
2022-04-11 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −18 500 | 6 985 334 | −0,26 | |||
2022-04-11 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,52 | −6 522 | |
2022-04-11 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-04-11 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-04-11 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,51 | −6 512 | |
2022-04-11 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 6,50 | −3 248 | |
2022-04-11 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2022-04-11 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 314 534 | −5,55 | 6,53 | −120 792 | 2 053 687 |
2022-04-11 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 333 034 | 5,88 | |||
2022-04-11 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 218 | 314 534 | −5,47 | 6,56 | −119 446 | 2 062 242 |
2022-04-11 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 44 010 | 332 752 | 15,24 | 2,48 | 109 145 | 825 225 |
2022-04-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 144 875 | −0,69 | |||
2022-04-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 144 875 | −0,69 | |||
2022-04-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −500 | 549 000 | −0,09 | |||
2022-04-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −44 010 | 1 383 334 | −3,08 | |||
2022-04-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −18 500 | 6 985 334 | −0,26 | |||
2022-04-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,56 | −6 561 | |
2022-04-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-04-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-04-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 6,57 | −6 568 | |
2022-04-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 6,55 | −3 277 | |
2022-04-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2022-04-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 288 742 | −6,02 | 6,56 | −121 434 | 1 895 302 |
2022-04-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 307 242 | 6,41 | |||
2022-04-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −17 326 | 288 742 | −5,66 | 7,00 | −121 279 | 2 021 136 |
2022-04-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 44 010 | 306 068 | 16,79 | 2,48 | 109 145 | 759 049 |
2022-04-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 145 875 | −0,68 | |||
2022-04-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 000 | 145 875 | −0,68 | |||
2022-04-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −500 | 549 500 | −0,09 | |||
2022-04-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −44 010 | 1 427 344 | −2,99 | |||
2022-04-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −18 500 | 7 003 834 | −0,26 | |||
2022-04-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 7,31 | −7 309 | |
2022-04-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 7,31 | −7 309 | |
2022-04-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-04-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 000 | 1 000 | ||||
2022-04-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 7,33 | −3 666 | |
2022-04-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 500 | 500 | ||||
2022-04-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −18 500 | 262 058 | −6,59 | 7,31 | −135 176 | 1 914 805 |
2022-04-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 18 500 | 280 558 | 7,06 | |||
2022-04-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −15 972 | 262 058 | −5,74 | 7,58 | −121 058 | 1 986 242 |
2022-04-07 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 44 010 | 278 030 | 18,81 | 2,48 | 109 145 | 689 514 |
2022-03-15 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | −6 150 | 7 022 334 | −0,09 | ||||
2022-03-15 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | −6 150 | 234 020 | −2,56 | 6,08 | −37 407 | 1 423 427 | |
2022-03-15 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | 6 150 | 240 170 | 2,63 | ||||
2022-03-15 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | −230 000 | 7 028 484 | −3,17 | ||||
2022-03-15 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | −230 000 | 234 020 | −49,57 | 6,28 | −1 444 814 | 1 470 067 | |
2022-03-15 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | 230 000 | 464 020 | 98,28 | ||||
2022-03-15 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | −100 000 | 7 258 484 | −1,36 | ||||
2022-03-15 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | −100 000 | 234 020 | −29,94 | 6,95 | −694 580 | 1 625 456 | |
2022-03-15 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | 100 000 | 334 020 | 42,73 | ||||
2022-03-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | −300 000 | 7 358 484 | −3,92 | ||||
2022-03-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | −300 000 | 234 020 | −56,18 | 7,30 | −2 188 950 | 1 707 527 | |
2022-03-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | 300 000 | 534 020 | 128,19 | ||||
2022-02-24 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | −100 000 | 7 658 484 | −1,29 | ||||
2022-02-24 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | −100 000 | 234 020 | −29,94 | 10,22 | −1 021 540 | 2 390 608 | |
2022-02-24 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | 100 000 | 334 020 | 42,73 | ||||
2022-02-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy) |
A - Award | 5 436 | 5 436 | |||||
2022-02-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy) |
A - Award | 416 350 | 416 350 | |||||
2022-02-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
F - Taxes | −343 | 234 020 | −0,15 | 11,40 | −3 910 | 2 667 828 | |
2022-02-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
A - Award | 2 718 | 234 363 | 1,17 | ||||
2022-02-08 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
A - Award | 208 175 | 231 645 | 886,98 | ||||
2022-02-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | −19 858 | 7 758 484 | −0,26 | ||||
2022-02-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | −19 858 | 23 470 | −45,83 | 11,73 | −232 964 | 275 338 | |
2022-02-02 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | 19 858 | 43 328 | 84,61 | ||||
2022-01-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | −254 000 | 7 778 342 | −3,16 | ||||
2022-01-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | −254 000 | 23 470 | −91,54 | 13,57 | −3 445 612 | 318 380 | |
2022-01-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | 254 000 | 277 470 | 1 082,23 | ||||
2022-01-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | −87 000 | 8 032 342 | −1,07 | ||||
2022-01-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | −8 794 | 23 470 | −27,26 | 14,96 | −131 575 | 351 156 | |
2022-01-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | −78 206 | 32 264 | −70,79 | 14,26 | −1 114 991 | 459 991 | |
2022-01-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | 87 000 | 110 470 | 370,69 | ||||
2022-01-14 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
G - Gift | −75 000 | 8 119 342 | −0,92 | ||||
2021-12-20 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −200 | 8 194 342 | 0,00 | |||
2021-12-20 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −200 | 23 470 | −0,84 | 20,00 | −4 001 | 469 517 |
2021-12-20 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 200 | 23 670 | 0,85 | |||
2021-12-15 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −100 | 8 194 542 | 0,00 | |||
2021-12-15 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −100 | 23 470 | −0,42 | 20,02 | −2 002 | 469 752 |
2021-12-15 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 100 | 23 570 | 0,43 | |||
2021-12-10 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −1 086 | 8 194 642 | −0,01 | |||
2021-12-10 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −1 086 | 23 470 | −4,42 | 20,01 | −21 730 | 469 614 |
2021-12-10 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 1 086 | 24 556 | 4,63 | |||
2021-12-10 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
C - Conversion | X | −5 488 | 8 195 728 | −0,07 | |||
2021-12-10 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −28 646 | 1 471 354 | −1,91 | |||
2021-12-10 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −5 488 | 23 470 | −18,95 | 20,26 | −111 162 | 475 397 |
2021-12-10 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
C - Conversion | X | 5 488 | 28 958 | 23,38 | |||
2021-12-10 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
S - Sale | X | −5 176 | 23 470 | −18,07 | 20,03 | −103 670 | 470 081 |
2021-12-10 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class A Common Stock |
M - Exercise | X | 28 646 | 28 646 | 2,47 | 70 756 | 70 756 | |
2021-12-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
S - Sale | X | −100 | 146 875 | −0,07 | 21,07 | −2 107 | 3 094 656 |
2021-12-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
S - Sale | X | −3 025 | 146 975 | −2,02 | 20,49 | −61 994 | 3 012 076 |
2021-12-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
S - Sale | X | −1 200 | 8 201 216 | −0,01 | 21,06 | −25 267 | 172 683 164 |
2021-12-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
S - Sale | X | −15 467 | 8 202 416 | −0,19 | 20,43 | −316 065 | 167 614 730 |
2021-12-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
G - Gift | 550 000 | 550 000 | |||||
2021-12-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
G - Gift | 550 000 | 550 000 | |||||
2021-12-09 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
G - Gift | −1 100 000 | 8 217 883 | −11,81 | ||||
2021-04-22 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy) |
C - Conversion | 1 500 000 | 1 500 000 | |||||
2021-04-22 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy) |
C - Conversion | −1 500 000 | 0 | −100,00 | ||||
2021-04-22 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Series A-1 Preferred Stock |
C - Conversion | −32 685 | 0 | −100,00 | ||||
2021-04-22 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Serie A Preferred Stock |
C - Conversion | −22 698 | 0 | −100,00 | ||||
2021-04-22 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
J - Other | 150 000 | 150 000 | |||||
2021-04-22 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Common Stock |
J - Other | −150 000 | 0 | −100,00 | ||||
2021-04-22 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Class B Common Stock |
J - Other | 9 317 883 | 9 317 883 | |||||
2021-04-22 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Common Stock |
J - Other | −9 317 883 | 0 | −100,00 | ||||
2021-04-22 |
|
4 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Common Stock |
C - Conversion | 55 383 | 9 317 883 | 0,60 | ||||
2021-04-15 | 3 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Common Stock |
9 262 500 | ||||||||
2021-04-15 | 3 | RXRX |
RECURSION PHARMACEUTICALS, INC.
Common Stock |
150 000 |